Retinal Ganglion Cell Bioenergetics with Clinical Translation

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1102568

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Glaucoma is an eye disease where elevated pressure within the eye damages the sensitive nerve of sight at the back of the eye. The only current treatment is to lower the pressure in the eye with either drops, laser or surgery. Why the pressure damages the nerve of sight is unclear but there is evidence that it results in a reduced blood flow to the nerve. This starves the nerve of nutrients. We have developed a new treatment that supplies nutrients to the nerve and protects vision.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2019

Funding Scheme: Project Grants

Funding Amount: $725,913.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Ophthalmology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

bioenergetics | clinical research | energy metabolism | glaucoma | neuroprotection

Related Links